TP53 and cancer: Furthermore, Taura et al. and Shatz et al. demonstrated that p53 activation upregulates the expression and function of toll-like receptors (TLR)-3 or −8 in human cancers, lymphocytes, alveolar type I cells, and epithelial cell lines [27,112,113].